MOH — authorised 24 December 1987
- Marketing authorisation holder: MEDA PHARMS
- Status: likely_approved
MOH authorised Rowasa on 24 December 1987
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 24 December 1987.
MEDA PHARMS holds the UAE marketing authorisation.